The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

OBJECTIVE: We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa. METHODS: We parameterised a population-...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer-Rath, Gesine, Schnippel, Kathryn, Long, Lawrence, MacLeod, William, Sanne, Ian, Stevens, Wendy, Pillay, Sagie, Pillay, Yogan, Rosen, Sydney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365041/
https://www.ncbi.nlm.nih.gov/pubmed/22693561
http://dx.doi.org/10.1371/journal.pone.0036966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365041/
https://www.ncbi.nlm.nih.gov/pubmed/22693561
http://dx.doi.org/10.1371/journal.pone.0036966

Ejemplares similares